FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP) Earnings History & Surprises
NASDAQ:FBIOP • US34960Q2084
13.635 USD
-0.02 (-0.11%)
At close: Mar 10, 2026
13.65 USD
+0.02 (+0.11%)
After Hours: 3/10/2026, 5:20:02 PM
Past quarterly earnings results for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMar 24, 2026
PeriodQ4 / 2025
EPS Estimate$0.11
Revenue Estimate26.693M
Last Reported
Release DateNov 14, 2025
PeriodQ3 / 2025
EPS Reported$0.11
EPS Surprise 125.68%
Revenue Surprise -17.76%
Beat Rate
56%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 0.11 | -0.43 | 125.68% | 114.47% | 17.631M | 21.439M | -17.76% | 20.52% |
| Q2 2025 | -0.50 | -0.37 | -36.17% | 31.51% | 16.413M | 14.825M | 10.71% | 10.18% |
| Q1 2025 | -0.48 | -0.50 | 4.93% | 53.40% | 13.139M | 11.853M | 10.85% | 0.84% |
| Q4 2024 | -0.75 | -0.77 | 2.39% | 41.41% | 15.12M | 16.623M | -9.04% | -24.20% |
| Q3 2024 | -0.76 | -0.61 | -25.23% | 19.15% | 14.629M | 32.862M | -55.48% | -57.90% |
| Q2 2024 | -0.73 | -1.25 | 41.50% | 79.72% | 14.896M | 15.068M | -1.14% | -14.32% |
| Q1 2024 | -1.03 | -1.76 | 41.63% | 67.30% | 13.03M | 14.413M | -9.60% | 4.84% |
| Q4 2023 | -1.28 | -2.01 | 36.19% | 71.30% | 19.946M | 15.192M | 31.29% | 21.62% |
| Q3 2023 | -0.94 | -3.27 | 71.25% | 74.93% | 34.752M | 14.869M | 133.72% | 110.24% |
| Q2 2023 | -3.60 | -3.48 | -3.43% | - | 17.386M | 15.884M | 9.46% | -7.96% |
| Q1 2023 | -3.15 | -3.06 | -2.94% | -16.67% | 12.429M | 17.762M | -30.02% | -48.06% |
| Q4 2022 | -4.46 | -3.44 | -29.57% | 21.74% | 16.4M | 22.495M | -27.09% | -10.28% |
| Q3 2022 | -3.75 | -4.13 | 9.22% | -78.57% | 16.53M | 21.248M | -22.20% | -21.62% |
| Q2 2022 | -3.60 | -3.21 | -12.04% | 17.24% | 18.89M | 23.643M | -20.10% | 5.89% |
| Q1 2022 | -2.70 | -4.28 | 36.97% | -63.64% | 23.93M | 21.087M | 13.48% | 106.47% |
| Q4 2021 | -5.70 | 2.69 | -311.68% | -660.00% | 18.28M | 49.282M | -62.91% | 32.95% |
| Q3 2021 | -2.10 | -1.25 | -68.06% | 30.00% | 21.09M | 18.792M | 12.23% | 122.47% |
| Q2 2021 | -4.35 | -1.91 | -127.45% | -52.63% | 17.84M | 14.987M | 19.04% | 88.58% |
| Q1 2021 | -1.65 | -1.65 | 0.15% | 42.11% | 11.59M | 13.681M | -15.28% | -10.29% |
| Q4 2020 | -0.75 | -2.14 | 64.99% | - | 13.75M | 12.407M | 10.82% | - |
| Q3 2020 | -3.00 | -3.34 | 10.19% | - | 9.48M | 11.548M | -17.91% | - |
| Q2 2020 | -2.85 | -4.07 | 29.97% | - | 9.46M | 11.252M | -15.93% | - |
| Q1 2020 | -2.85 | -3.52 | 19.01% | - | 12.92M | 11.521M | 12.14% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
24.21%
Max EPS beat (4)
125.68%
Min EPS beat (4)
-36.17%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-1.31%
Max Revenue beat (4)
10.85%
Min Revenue beat (4)
-17.76%
Analysis
In the last 4 quarters, FBIOP has beaten EPS estimates in 3 out of 4 releases
FBIOP has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, FBIOP has beaten the EPS estimates by 24.2% on average.
In the last 4 quarters, FBIOP reported -1.3% below the revenue estimates on average.
FORTRESS BIOTECH INC - FBIO 9 3/8 PERP / FBIOP Earnings FAQ
Can you provide the last earnings date for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP?
FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP) last reported earnings on 11/14/2025.
Did FBIOP stock beat earnings estimates in the most recent quarter?
FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does FBIOP stock beat earnings estimates?
In the last 4 quarters, FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP) has beaten EPS estimates in 3 out of 4 releases.